Edward J. P. Cartwright
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Edward J. P. Cartwright has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Julian Parkhill
Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom
6 shared publications - Mili Estee Torok
Department of Medicine, University of Cambridge, Cambridge, UK
5 shared publications - Claudio Umberto Köser
Department of Genetics, University of Cambridge, Cambridge, UK
4 shared publications - Matthew T. G. Holden
School of Medicine, University of St Andrews, St Andrews, Scotland, United Kingdom
4 shared publications - Simon R. Harris
Wellcome Sanger Institute
4 shared publications Sharon J Peacock
Department of Medicine, University of Cambridge, Cambridge, UK Department of Microbiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK Public Health England, Clinical Microbiology and Public Health Laboratory, Cambridge, UK Wellcome Trust Sanger Institute, Hinxton, UK
3 shared publications
Latest Publications
- Open Access
Impact of infectious diseases consultation on the management of Staphylococcus aureus bacteraemia in children
Objectives: Infectious diseases consultation (IDC) in adults with Staphylococcus aureus bacteraemia (SAB) has been shown to improve management and outcome. The aim of this study was to evaluate the impact of IDC on the management of SAB in children. Study design: Observational cohort study of children with SAB. Setting: Cambridge University Hospitals National Health Service (NHS) Foundation Trust, a large acute NHS Trust in the UK. Participants: All children with SAB admitted to the Cambridge University Hospitals NHS Foundation Trust between 16 July 2006 and 31 December 2012. Methods: Children with SAB between 2006 and 31 October 2009 were managed by routine clinical care (pre-IDC group) and data were collected retrospectively by case notes review. An IDC service for SAB was introduced in November 2009. All children with SAB were reviewed regularly and data were collected prospectively (IDC group) until 31 December 2012. Baseline characteristics, quality metrics and outcome were compared between the pre-IDC group and IDC group. Results: There were 66 episodes of SAB in 63 children—28 patients (30 episodes) in the pre-IDC group, and 35 patients (36 episodes) in the IDC group. The median age was 3.4 years (IQR 0.2–10.7 years). Patients in the IDC group were more likely to have echocardiography performed, a removable focus of infection identified and to receive a longer course of intravenous antimicrobial therapy. There were no differences in total duration of antibiotic therapy, duration of hospital admission or outcome at 30 or 90 days following onset of SAB. Conclusions: IDC resulted in improvements in the investigation and management of SAB in children.
Open AccessImpact of infectious diseases consultation on the management of Staphylococcus aureus bacteraemia in children
Objectives: Infectious diseases consultation (IDC) in adults with Staphylococcus aureus bacteraemia (SAB) has been shown to improve management and outcome. The aim of this study was to evaluate the impact of IDC on the management of SAB in children. Study design: Observational cohort study of children with SAB. Setting: Cambridge University Hospitals National Health Service (NHS) Foundation Trust, a large acute NHS Trust in the UK. Participants: All children with SAB admitted to the Cambridge University Hospitals NHS Foundation Trust between 16 July 2006 and 31 December 2012. Methods: Children with SAB between 2006 and 31 October 2009 were managed by routine clinical care (pre-IDC group) and data were collected retrospectively by case notes review. An IDC service for SAB was introduced in November 2009. All children with SAB were reviewed regularly and data were collected prospectively (IDC group) until 31 December 2012. Baseline characteristics, quality metrics and outcome were compared between the pre-IDC group and IDC group. Results: There were 66 episodes of SAB in 63 children—28 patients (30 episodes) in the pre-IDC group, and 35 patients (36 episodes) in the IDC group. The median age was 3.4 years (IQR 0.2–10.7 years). Patients in the IDC group were more likely to have echocardiography performed, a removable focus of infection identified and to receive a longer course of intravenous antimicrobial therapy. There were no differences in total duration of antibiotic therapy, duration of hospital admission or outcome at 30 or 90 days following onset of SAB. Conclusions: IDC resulted in improvements in the investigation and management of SAB in children.
- Open Access
- 12 August 2013
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 173 (15) , 1397-1404
Rapid Bacterial Whole-Genome Sequencing to Enhance Diagnostic and Public Health Microbiology
Antimicrobial resistance poses a grave threat to human health.1 Efforts to control the emergence and spread of drug-resistant organisms depend on rapid detection and effective treatment of cases combined with epidemiologic investigations and public health interventions to prevent ongoing transmission. Laboratory support for these activities begins with the detection, identification, and antimicrobial susceptibility testing of a pathogen, which are usually performed in a local diagnostic microbiology laboratory. For a minority of organisms, further identification, extended antimicrobial susceptibility testing, and/or confirmation of resistance mechanisms is required, which are commonly performed by reference laboratories. Such laboratories also perform molecular typing to assist epidemiologic investigations and public health surveillance, although current typing methods often lack sufficient resolution to allow accurate inferences regarding transmission events.2-11 Ideally, surveillance should be a dynamic process in which the flow of relevant information is monitored for a range of purposes, including the emergence of clinically significant drug resistance and detection of outbreaks.8 Currently, this information is gathered retrospectively, usually in response to an outbreak, and can fail to have an impact on disease control, as demonstrated by the recent Escherichia coli O104:H4 outbreak in Germany.12
- 12 August 2013
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 173 (15) , 1397-1404
Open AccessRapid Bacterial Whole-Genome Sequencing to Enhance Diagnostic and Public Health Microbiology
Antimicrobial resistance poses a grave threat to human health.1 Efforts to control the emergence and spread of drug-resistant organisms depend on rapid detection and effective treatment of cases combined with epidemiologic investigations and public health interventions to prevent ongoing transmission. Laboratory support for these activities begins with the detection, identification, and antimicrobial susceptibility testing of a pathogen, which are usually performed in a local diagnostic microbiology laboratory. For a minority of organisms, further identification, extended antimicrobial susceptibility testing, and/or confirmation of resistance mechanisms is required, which are commonly performed by reference laboratories. Such laboratories also perform molecular typing to assist epidemiologic investigations and public health surveillance, although current typing methods often lack sufficient resolution to allow accurate inferences regarding transmission events.2-11 Ideally, surveillance should be a dynamic process in which the flow of relevant information is monitored for a range of purposes, including the emergence of clinically significant drug resistance and detection of outbreaks.8 Currently, this information is gathered retrospectively, usually in response to an outbreak, and can fail to have an impact on disease control, as demonstrated by the recent Escherichia coli O104:H4 outbreak in Germany.12
- Open Access
- 1 August 2013
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 51 (8) , 2732-2734
Use of Vitek 2 Antimicrobial Susceptibility Profile To Identify mecC in Methicillin-Resistant Staphylococcus aureus
The emergence of mecC methicillin-resistant Staphylococcus aureus (MRSA) poses a diagnostic challenge for clinical microbiology laboratories. Using the Vitek 2 system, we tested a panel of 896 Staphylococcus aureus isolates and found that an oxacillin-sensitive/cefoxitin-resistant profile had a sensitivity of 88.7% and a specificity of 99.5% for the identification of mecC MRSA isolates. The presence of the mecC gene, determined by bacterial whole-genome sequencing, was used as the gold standard. This profile could provide a zero-cost screening method for identification of mecC -positive MRSA strains.
- 1 August 2013
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 51 (8) , 2732-2734
Open AccessUse of Vitek 2 Antimicrobial Susceptibility Profile To Identify mecC in Methicillin-Resistant Staphylococcus aureus
The emergence of mecC methicillin-resistant Staphylococcus aureus (MRSA) poses a diagnostic challenge for clinical microbiology laboratories. Using the Vitek 2 system, we tested a panel of 896 Staphylococcus aureus isolates and found that an oxacillin-sensitive/cefoxitin-resistant profile had a sensitivity of 88.7% and a specificity of 99.5% for the identification of mecC MRSA isolates. The presence of the mecC gene, determined by bacterial whole-genome sequencing, was used as the gold standard. This profile could provide a zero-cost screening method for identification of mecC -positive MRSA strains.
- 9 July 2013
- Published by Springer Nature in Nature Biotechnology
- Vol. 31 (7) , 592-594
Read and assembly metrics inconsequential for clinical utility of whole-genome sequencing in mapping outbreaks
- 9 July 2013
- Published by Springer Nature in Nature Biotechnology
- Vol. 31 (7) , 592-594
Read and assembly metrics inconsequential for clinical utility of whole-genome sequencing in mapping outbreaks
- Top Cited PapersOpen Access
- 1 February 2013
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 13 (2) , 130-136
Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study
- 1 February 2013
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 13 (2) , 130-136
Top Cited PapersOpen AccessWhole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study
- Top Cited PapersOpen Access
- 2 August 2012
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 8 (8) , e1002824
Routine Use of Microbial Whole Genome Sequencing in Diagnostic and Public Health Microbiology
This work is partly supported by funding from the Medical Research Council, the European Developing Country Clinical Trials Partnership, the Global Alliance for TB Drug Development, and the European Union.Whole genome sequencing (WGS) promises to be transformative for the practice of clinical microbiology, and the rapidly falling cost and turnaround time mean that this will become a viable technology in diagnostic and reference laboratories in the near future. The objective of this article is to consider at a very practical level where, in the context of a modern diagnostic microbiology laboratory, WGS might be cost-effective compared to current alternatives. We propose that molecular epidemiology performed for surveillance and outbreak investigation and genotypic antimicrobial susceptibility testing for microbes that are difficult to grow represent the most immediate areas for application of WGS, and discuss the technical and infrastructure requirements for this to be implemented.Publisher PDFPeer reviewe
- 2 August 2012
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 8 (8) , e1002824
Top Cited PapersOpen AccessRoutine Use of Microbial Whole Genome Sequencing in Diagnostic and Public Health Microbiology
This work is partly supported by funding from the Medical Research Council, the European Developing Country Clinical Trials Partnership, the Global Alliance for TB Drug Development, and the European Union.Whole genome sequencing (WGS) promises to be transformative for the practice of clinical microbiology, and the rapidly falling cost and turnaround time mean that this will become a viable technology in diagnostic and reference laboratories in the near future. The objective of this article is to consider at a very practical level where, in the context of a modern diagnostic microbiology laboratory, WGS might be cost-effective compared to current alternatives. We propose that molecular epidemiology performed for surveillance and outbreak investigation and genotypic antimicrobial susceptibility testing for microbes that are difficult to grow represent the most immediate areas for application of WGS, and discuss the technical and infrastructure requirements for this to be implemented.Publisher PDFPeer reviewe
- Top Cited Papers
- 14 June 2012
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 366 (24) , 2267-2275
Rapid Whole-Genome Sequencing for Investigation of a Neonatal MRSA Outbreak
Isolates of methicillin-resistant Staphylococcus aureus (MRSA) belonging to a single lineage are often indistinguishable by means of current typing techniques. Whole-genome sequencing may provide improved resolution to define transmission pathways and characterize outbreaks. We investigated a putative MRSA outbreak in a neonatal intensive care unit. By using rapid high-throughput sequencing technology with a clinically relevant turnaround time, we retrospectively sequenced the DNA from seven isolates associated with the outbreak and another seven MRSA isolates associated with carriage of MRSA or bacteremia in the same hospital. We constructed a phylogenetic tree by comparing single-nucleotide polymorphisms (SNPs) in the core genome to a reference genome (an epidemic MRSA clone, EMRSA-15 [sequence type 22]). This revealed a distinct cluster of outbreak isolates and clear separation between these and the nonoutbreak isolates. A previously missed transmission event was detected between two patients with bacteremia who were not part of the outbreak. We created an artificial “resistome” of antibiotic-resistance genes and demonstrated concordance between it and the results of phenotypic susceptibility testing; we also created a “toxome” consisting of toxin genes. One outbreak isolate had a hypermutator phenotype with a higher number of SNPs than the other outbreak isolates, highlighting the difficulty of imposing a simple threshold for the number of SNPs between isolates to decide whether they are part of a recent transmission chain. Whole-genome sequencing can provide clinically relevant data within a time frame that can influence patient care. The need for automated data interpretation and the provision of clinically meaningful reports represent hurdles to clinical implementation. (Funded by the U.K. Clinical Research Collaboration Translational Infection Research Initiative and others.)
- 14 June 2012
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 366 (24) , 2267-2275
Top Cited PapersRapid Whole-Genome Sequencing for Investigation of a Neonatal MRSA Outbreak
Isolates of methicillin-resistant Staphylococcus aureus (MRSA) belonging to a single lineage are often indistinguishable by means of current typing techniques. Whole-genome sequencing may provide improved resolution to define transmission pathways and characterize outbreaks. We investigated a putative MRSA outbreak in a neonatal intensive care unit. By using rapid high-throughput sequencing technology with a clinically relevant turnaround time, we retrospectively sequenced the DNA from seven isolates associated with the outbreak and another seven MRSA isolates associated with carriage of MRSA or bacteremia in the same hospital. We constructed a phylogenetic tree by comparing single-nucleotide polymorphisms (SNPs) in the core genome to a reference genome (an epidemic MRSA clone, EMRSA-15 [sequence type 22]). This revealed a distinct cluster of outbreak isolates and clear separation between these and the nonoutbreak isolates. A previously missed transmission event was detected between two patients with bacteremia who were not part of the outbreak. We created an artificial “resistome” of antibiotic-resistance genes and demonstrated concordance between it and the results of phenotypic susceptibility testing; we also created a “toxome” consisting of toxin genes. One outbreak isolate had a hypermutator phenotype with a higher number of SNPs than the other outbreak isolates, highlighting the difficulty of imposing a simple threshold for the number of SNPs between isolates to decide whether they are part of a recent transmission chain. Whole-genome sequencing can provide clinically relevant data within a time frame that can influence patient care. The need for automated data interpretation and the provision of clinically meaningful reports represent hurdles to clinical implementation. (Funded by the U.K. Clinical Research Collaboration Translational Infection Research Initiative and others.)
- 30 March 2011
- Published by Springer Nature in Nature
- Vol. 471 (7340) , 578
Microbial sequences benefit health now
- 30 March 2011
- Published by Springer Nature in Nature
- Vol. 471 (7340) , 578
Microbial sequences benefit health now